Professional Education
Module 6: Controlled Substance Utilization Review and Evaluation System (CURES) (Innovations and Smart Approaches in Safe Prescribing)
This program reviews the CURES electronic database for Schedule II, III, IV, V controlled substance prescriptions dispensed in California, including time requirements involved when dispensing information needs to be reported (a controlled substance is released to the patient or patient's representative). This module will examine how non-DEA licensed physicians and surgeon practitioners can access CURES data. This module consists of four audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
Search
Jan 30, 2025
Off-Label Use: Patient Safety Implications
Once authorized, a drug product may be prescribed by a licensed healthcare practitioner for any use deemed appropriate based on the practitioner’s professional opinion. The governing standard is what other similarly trained practitioners would do—not what the manufacturer of the medication or product recommends.
Expert Insights and Resources for Changing Healthcare
The Insurance Marketing and Communications Association (IMCA) recognized The Doctors Company for its exceptional efforts to educate and support healthcare professionals as they navigate the rapidly changing healthcare industry, especially as they adapt to evolving technologies.
Hurricanes Helene and Milton Assistance
Due to disruption to member medical practices from Hurricanes Helene and Milton and consistent with direction from state insurance regulation offices, The Doctors Company will adjust policy cancellation and premium installment due dates for affected members. Premium due dates have generally been extended in Florida, Georgia, North Carolina, South Carolina, and Tennessee.
June 25, 2025, Business Insurance
Doctors Aren’t Talking Up Their Career: Survey
According to a recent study conducted by The Doctors Company, only 12 percent of doctors are likely to recommend that people join their profession.
February 12, 2023, Medical Device & Technology
Urgency Needed for Medical Grade Wearables
David L. Feldman, MD, MBA, FACS, Chief Medical Officer, The Doctors Company and TDC Group, discusses the importance of understanding how technology like wearables impacts medical liability.
February 28, 2023, Medtech Insight
So the Public Health Emergency Is Over. Now What?
David L. Feldman, MD, MBA, FACS, Chief Medical Officer, The Doctors Company and TDC Group, provides insight about what the official end of the COVID-19 emergency means for average Americans.
May 12, 2025, Part B News
OK to Promote Your Practice to Outside Patients, but Watch Poaching Concerns
Richard Cahill, JD, Vice President and Associate General Counsel, The Doctors Company, part of TDC Group, provides considerations for healthcare providers when recruiting patients following a medical office closure.
March 03, 2025, Part B News
Bird Flu, Measles Spread: If You’re Nearby, Take Precautionary Steps
Rich Cahill, Vice President and Associate General Counsel for The Doctors Company, part of TDC Group, shares the most up-to-date guidance on managing bird flu and measles.
September 22, 2025, Part B News
Preventive Measures, Appropriate Responses Reduce Litigation Risks
You can’t eliminate the risk that a patient will sue your practice, but there are ways you can reduce the risk of lawsuits, protect your staff, and increase patient satisfaction at the same time.
